<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> has anti-<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> effects which are thought to be mediated by mismatch repair gene (MMR) activity </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> receptor (ER) expression is associated with microRNA (miRNA) expression in ER-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, studies of direct link between <z:chebi fb="0" ids="50114">estrogen</z:chebi> (especially <z:chebi fb="1" ids="23965">estradiol</z:chebi> E2), miRNA expression, and MMR in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) have not been done </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we first evaluated the effects of <z:chebi fb="1" ids="23965">estradiol</z:chebi> (E2) and its <z:chebi fb="68" ids="48706">antagonist</z:chebi> ICI182,780 on the expression of miRNAs (miR-31, miR-155 and miR-135b) using COLO205, SW480 and MCF-7 cell lines, followed by examining the association of tissue miRNA expression and serum E2 levels using samples collected from 18 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>E2 inhibited the expressions of miRNAs in COLO205 cells, which could be reversed by E2 <z:chebi fb="68" ids="48706">antagonist</z:chebi> ICI 182.780 </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of miR-135b was inversely correlated with serum E2 level and ER-β <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients' <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues </plain></SENT>
<SENT sid="6" pm="."><plain>There were significant correlations between serum E2 level and expression of ER-β, miR-135b, and MMR in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissue </plain></SENT>
<SENT sid="7" pm="."><plain>This study suggests that the effects of <z:chebi fb="0" ids="50114">estrogen</z:chebi> on MMR function may be related to regulating miRNA expression via ER-β, which may be the basis for the anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effect in colorectal cells </plain></SENT>
</text></document>